Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan

Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07701941

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Hematology Oncology Associates of Central New York, Camillus
Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07102381

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06625775

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Kings County Hopsital Center, Brooklyn
Queens Cancer Center of Queens Hospital, Jamaica
Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
dan 1 lagi

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT04751435

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

University of Rochester Medical Center, Rochester

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06369285

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

Roswell Park Comprehensive Cancer Center, Buffalo

Mengambil pesertaFasa 2

Umur 70 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT04305834

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Memorial Sloan-Kettering Cancer Center, New York
New York Cancer & Blood Specialists, Shirley

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06324357

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer

Memorial Sloan Kettering Suffolk- Commack (Consent Only), Commack
Memorial Sloan Kettering Westchester (Consent Only), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
dan 1 lagi

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07218250

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

New York Proton Center, New York

Mengambil pesertaFasa 3

Umur 19 ke atas · Wanita · Dikemas kini 29 Sep 2026 · NCT05856773

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, New York

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05877599

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

New York Proton Center, New York

Mengambil pesertaFasa 2

Umur 50 ke atas · Wanita · Dikemas kini 29 Sep 2026 · NCT01766297

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Mineola
Avenzo Therapeutics Recruiting Site, New York

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05867251

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Queens Hospital Cancer Center ( Site 0011), Jamaica
Optum Medical Care, PC ( Site 0009), Westbury

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07060807

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

NYU Langone Health - Brooklyn ( Site 0089), Brooklyn
NYU Langone Hospital - Long Island ( Site 0090), Mineola
Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0068), New York
dan 2 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06312176

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, New York
Research Site, Stony Brook

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07007559

A Study of Language Interpretation Solutions for People With Breast Cancer

Memorial Sloan Kettering Suffolk- Commack (Consent Only), Commack
Memorial Sloan Kettering Westchester (Consent Only), Harrison
Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities), New York
dan 2 lagi

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06721065

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
dan 1 lagi

Mengambil pesertaFasa 1

Umur 18 ke atas · Wanita · Dikemas kini 24 Sep 2026 · NCT05412225

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, New York
Clinical Trial Site, New York

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07085767

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

New York Cancer and Blood Specialists, Babylon
NYU Langone Health, New York
University of Rochester (URMC), Rochester
dan 1 lagi

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

NYOH Albany Cancer Center, Albany
New York University (NYU) Brooklyn, Brooklyn
Memorial Sloan Kettering Cancer Center, New York
dan 1 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07174336

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

New York University (NYU) Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07114601

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Memorial Sloan Kettering Cancer Center, New York
Wilmot Cancer Institute, Rochester
New York Cancer and Blood Specialists, Shirley

Mengambil pesertaFasa 2

Umur 18 ke atas · Wanita · Dikemas kini 22 Sep 2026 · NCT07287098

Intra-Operative Radiation Registry

Montefiore Medical Center - Moses Campus, The Bronx

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Wanita · Dikemas kini 22 Sep 2026 · NCT04994067

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

New York University (NYU) Clinical Cancer Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07213791

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Weill Cornell Medicine, New York

Mengambil pesertaSukarelawan sihat dialu-alukan

Umur 30 hingga 74 · Wanita · Dikemas kini 21 Sep 2026 · NCT02620852

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
dan 1 lagi

Mengambil pesertaFasa 2

Umur 45 ke atas · Wanita · Dikemas kini 21 Sep 2026 · NCT04084730

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Paradigm New York Cancer and Blood Specialists, Bay Shore
Paradigm New York Cancer and Blood Specialists, New York
Paradigm New York Cancer and Blood Specialists, New York
dan 9 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07173751

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Memorial Sloan Kettering Cancer Center Westchester, Harrison
Beth Israel Comprehensive Cancer Center, New York
Mount Sinai Medical Center, New York
dan 5 lagi

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06827236

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

Memorial Sloan Kettering Cancer Center (All protocol activites), New York

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan

Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06780176

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Kings County Hospital Center, Brooklyn
Hematology Oncology Associates of Central New York, PC, East Syracuse
Cayuga Medical Center, Ithaca
dan 9 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06492616

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activites), New York
dan 1 lagi

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06246968

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Commack

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT05123482

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.